Anergis

Anergis is a clinical-stage biopharmaceutical company that discovers and develops allergy vaccines based on the contiguous overlapping peptide technology for ultra-fast desensitization. It provides vaccines targeting birch pollen, ragweed pollen, and house dust mite allergies.